Table 1. Summary of NOX4 expression and clinicopathological feature in the lung cancer patients.
|
NOX4 expression |
||||
|---|---|---|---|---|
| Patient character | Number | −, + | ++,+++ | P-value |
|
Sex | ||||
| Male | 76 | 11 (14.5) | 65 (85.5) | 0.372 |
| Female | 20 | 5 (25) | 15 (75) | |
|
Age | ||||
| ⩽57 | 34 | 9 (26.5) | 26 (73.5) | 0.48 |
| >57 | 62 | 7 (11.3) | 55 (88.7) | |
|
Clinical stage | ||||
| I | 36 | 6 (16.7) | 30 (83.3) | 0.51 |
| II | 38 | 6 (15.8) | 32 (84.2) | |
| II | 22 | 4 (18.2) | 18 (81.8) | |
|
N classification | ||||
| N0 | 55 | 9 (16.4) | 46 (83.6) | 0.20 |
| N1 | 24 | 4 (16.7) | 20 (83.3) | |
| N2 | 17 | 3 (13.6) | 14 (63.6) | |
|
T classification | ||||
| T1 | 8 | 2 (25) | 6 (75) | 0.52 |
| T2 | 72 | 11 (15.3) | 61 (84.7) | |
| T3 | 10 | 3 (30) | 7 (70) | |
| T4 | 6 | 0 (0) | 6 (100) | |
|
Histology | ||||
| Adenocarcinoma | 26 | 6 (23) | 20 (77) | |
| Squamous carcinoma | 49 | 6 (12) | 43 (88) | 0.682 |
| Others | 21 | 4 (19) | 17 (81) | 0.5 |